Does BOTULINUM TOXIN TYPE A Cause C-reactive protein increased? 527 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 527 reports of C-reactive protein increased have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 14.1% of all adverse event reports for BOTULINUM TOXIN TYPE A.
527
Reports of C-reactive protein increased with BOTULINUM TOXIN TYPE A
14.1%
of all BOTULINUM TOXIN TYPE A reports
524
Deaths
444
Hospitalizations
How Dangerous Is C-reactive protein increased From BOTULINUM TOXIN TYPE A?
Of the 527 reports, 524 (99.4%) resulted in death, 444 (84.3%) required hospitalization, and 450 (85.4%) were considered life-threatening.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 527 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower C-reactive protein increased Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE